Skip to main content
Log in

Contribution of the monocyte to thrombotic potential

  • Inflammatory Cells
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The circulating monocyte exhibits the capacity to initiate and accelerate the coagulation cascade. We have devised a simple whole blood clotting assay which quantitates the monocyte's contribution of procoagulant (a marker of monocyte activation) to the clotting process and in addition, measures thein vivo activation of the cell. Citrated whole blood is added to saline and the recalcification time (RT) determined without incubation (RT control), with two hours incubation (RT saline), or added to endotoxin with incubation (RT endotoxin). The reduction in value between RT control and RT saline is a measure of monocyte activationin vivo. The reduction, in time between RT saline and RT endotoxin is a marker of monocyte activationin vitro. This simple test enables the measurement of monocyte activation and this cells contribution to the hypercoagulability described in many disease states.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. R. L. Edwards, F. R. Rickles and M. Cronlund,Abnormalities of blood coagulation in patients with cancer. J. Lab. Clin. Med.98, 917–928 (1981).

    PubMed  Google Scholar 

  2. B. Osterud and E. Bjorklid,The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. Scand. Haematol.29, 175–184 (1982).

    Google Scholar 

  3. C. R. Spillert, C. T. Curtis and E. J. Lazaro,Assessment of monocyte function in the diagnosis of breast disease. South Med J81, 164–166 (1988).

    PubMed  Google Scholar 

  4. J. N. McCullough, C. R. Spillert and E. J. Lazaro,A direct correlation between injury severity and two markers of the functional status of the immune system. Circ. Shock.31, 309–316 (1990).

    PubMed  Google Scholar 

  5. C. R. Spillert, J. T. Milazzo, W. D. Suval and E. J. Lazaro,Hypercoagulability in arterial disease. Angiology.40, 886–889 (1989).

    PubMed  Google Scholar 

  6. C. R. Spillert, V. J. Milazzo, J. A. Pastena and E. J. Lazaro,Prediction of clinical course of diabetes utilizing a simple coagulation test. J. Natl. Med. Assoc.81, 81–83 (1989).

    PubMed  Google Scholar 

  7. K. S. Dasmahapatra, N. R. Cheung, C. R. Spillert and E. J. Lazaro,An assessment of monocyte procoagulant activity in patients with solid tumors. J. Surg. Res.43, 158–169 (1987).

    PubMed  Google Scholar 

  8. C. R. Spillert, M. P. Hafstein, V. Lanke and E. J. Lazaro,Increased thromboplastin production in multiple sclerosis: An immunologic defect? Ann. NY Acad. Sci.475, 345–346 (1986).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spillert, C.R., Lazaro, E.J. Contribution of the monocyte to thrombotic potential. Agents and Actions 34, 28–29 (1991). https://doi.org/10.1007/BF01993228

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01993228

Keywords

Navigation